EU approves Pfizer’s RSV vaccine to protect infants and older adults

(Reuters) – The European Commission on Thursday approved Pfizer’s vaccine for respiratory syncytial virus (RSV) for use in babies and older adults.

(Reporting by Sriparna Roy in Bengaluru; Editing by Arun Koyyur)